(1)
Haemophilus Influenzae Type B Polyribosylribitol Phosphate-Tetanus (Hib PRP-T) Vaccine Safety, Phase I Study. IJIHS 2015, 3 (2), 55-59. https://doi.org/10.15850/ijihs.v3n2.584.